Geode Capital Management, LLC Keros Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.52 Trillion
Q3 2025

A detailed history of Geode Capital Management, LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 837,363 shares of KROS stock, worth $14.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

837,363

Previous 829,297 0.97%

Holding current value

$14.5 Million

Previous $11.1 Million 19.65%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$13.34 - $16.05 $107,600 - $129,459	8,066 Added 0.97%	837,363 $13.2 Million
Q2 2025 Aug 08, 2025	BUY	$9.55 - $15.11 $220,719 - $349,222	23,112 Added 2.87%	829,297 $11.1 Million
Q1 2025 May 13, 2025	BUY	$10.15 - $16.1 $413,602 - $656,058	40,749 Added 5.32%	806,185 $8.22 Million
Q4 2024 Feb 12, 2025	BUY	$15.64 - $70.0 $622,706 - $2.79 Million	39,815 Added 5.49%	765,436 $12.1 Million
Q3 2024 Nov 12, 2024	BUY	$41.68 - $58.07 $1.92 Million - $2.67 Million	46,041 Added 6.77%	725,621 $42.1 Million

Q2 2024 Aug 09, 2024	BUY	$44.58 - $66.89 $3.73 Million - $5.6 Million	83,734 Added 14.05%	679,580 $31.1 Million
Q1 2024 May 13, 2024	BUY	$41.26 - $70.48 $3.53 Million - $6.04 Million	85,635 Added 16.78%	595,846 $39.4 Million
Q4 2023 Feb 13, 2024	BUY	$27.12 - $41.05 $656,575 - $993,820	24,210 Added 4.98%	510,211 $20.3 Million
Q3 2023 Nov 13, 2023	BUY	$31.57 - $43.02 $2.06 Million - $2.81 Million	65,279 Added 15.52%	486,001 $15.5 Million
Q2 2023 Aug 11, 2023	BUY	$37.26 - $51.01 $1.96 Million - $2.69 Million	52,676 Added 14.31%	420,722 $16.9 Million
Q1 2023 May 15, 2023	BUY	$41.44 - $59.32 $758,269 - $1.09 Million	18,298 Added 5.23%	368,046 $15.7 Million
Q4 2022 Feb 13, 2023	BUY	$39.45 - $51.77 $1.33 Million - $1.74 Million	33,599 Added 10.63%	349,748 $16.8 Million
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $1.15 Million - $1.65 Million	41,247 Added 15.0%	316,149 $11.9 Million
Q2 2022 Aug 12, 2022	BUY	$26.03 - $67.04 $1,535 - $3,955	59 Added 0.02%	274,902 $7.6 Million
Q1 2022 May 13, 2022	BUY	$42.12 - $59.36 $804,323 - $1.13 Million	19,096 Added 7.47%	274,843 $14.9 Million
Q4 2021 Feb 11, 2022	BUY	$36.95 - $62.89 $1.59 Million - $2.7 Million	42,941 Added 20.18%	255,747 $15 Million
Q3 2021 Nov 12, 2021	SELL	$29.27 - $43.71 $225,993 - $337,484	-7,721 Reduced 3.5%	212,806 $8.42 Million
Q2 2021 Aug 13, 2021	BUY	$42.4 - $70.11 $1.97 Million - $3.26 Million	46,506 Added 26.72%	220,527 $9.37 Million
Q1 2021 May 12, 2021	BUY	$54.0 - $75.28 $894,294 - $1.25 Million	16,561 Added 10.52%	174,021 $10.7 Million
Q4 2020 Feb 12, 2021	BUY	$36.0 - $82.74 $1.71 Million - $3.92 Million	47,432 Added 43.11%	157,460 $11.1 Million
Q3 2020 Nov 13, 2020	BUY	$27.04 - $62.21 $75,712 - $174,188	2,800 Added 2.61%	110,028 $4.24 Million
Q2 2020 Aug 13, 2020	BUY	$20.08 - $40.39 $2.15 Million - $4.33 Million	107,228 New	107,228 $4.02 Million

Others Institutions Holding KROS

# of Institutions

169

Shares Held

35.4M

Call Options Held

574K

Put Options Held

325K

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $445M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Keros Therapeutics, Inc. Transaction History